Tata Elxsi Q2 FY27 Earnings Call — Analysis (NSE: TATAELXSI)
Tata Elxsi reported 2.3% CC sequential revenue growth to ₹1,055.7 Cr with EBITDA margin expanding 70 bps QoQ to 21.9% despite wage revisions, led by recovery across Media, Healthcare, and non-European Auto.
Result quality: stable — Steady quarter. Management sentiment: optimistic.
The take
Q2FY27 Operating Revenue ₹1,055.7 Cr ( +2.3% QoQ ) . New guidance — Q1FY28 multi-quarter gradual ebitda ma… gradual improvement . New story: Media & communications vertical revival .
Results
Revenue reached ₹1,055.7 Cr (+2.3% QoQ CC); EBITDA stood at ₹231.4 Cr (+7.1% QoQ, +19.7% YoY) with EBITDA margin at 21.9% (+70bps QoQ).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Operating Revenue | ₹1,055.7 Cr | +2.3% | qoq · Q2FY27 · constant currency |
| EBITDA | ₹231.4 Cr | +7.1% | qoq · Q2FY27 |
| EBITDA | ₹231.4 Cr | +19.7% | yoy · Q2FY27 |
| EBITDA Margin | 21.9% | +70bps | qoq · Q2FY27 |
| Utilization Rate | 78% | point_in_time · Q2FY27 · Sep-26 |
Guidance
Management expects H2FY27 performance to be better than H1FY27 across Media, Healthcare, and non-Europe Auto, accompanied by gradual margin improvement via operational leverage and pyramid optimization.
What management committed to
- We expect 2H to be better than 1H, it would imply that our revenues would be higher even on a Y-o-Y basis in H2. — H2FY27
- We will see that gradual improvement in our margins over the next, I would say, 2 to 3 quarters. — gradual improvement, Q1FY28
- Even in the healthcare business H2 will be better than H1 for us. — H2FY27
Key themes
Broad-based recovery and margin resilience
How the narrative shifted
- Media & communications vertical revival: No reframing needed; the trajectory delivered on prior guidance.
- Automotive resilience in Europe headwinds: Europe's weakness is now explicitly attributed to OEM-specific delays in large deal decision-making, not just macro demand.
- Investment-led margin compression: Replaced the prior 'transitory cost compression' story with a 'recovery via leverage and pyramid management' story, as the discrete one-off costs have been eliminated.
- AI and platform differentiation: Added a sub-narrative of enterprise AI ROI realism to the existing bullish AI adoption story.
- Healthcare growth deferred: Previously a 'disappointing' deferral story, it is now recast as a 'bottomed-out and recovering' success, leveraging new client wins.
- US revenue surge with near-term cost: The cost issue is largely resolved; the thread now emphasizes sustained growth without the structural penalty.
- Pyramid correction and operational leverage: Having absorbed one-time costs and wage hikes, management signals the next margin lever is active pyramid management—shifting the senior-to-junior mix—and improving utilization toward the 81-82% peak.
- Enterprise AI ROI realism: Enterprises are becoming more prudent with AI budgets, demanding clear ROI, which plays to the strengths of experienced engineering partners over pure experimentation.
Operational commentary
- Won a multi-year deal from a leading automotive OEM for next-generation cloud-based telematics and connected vehicle ecosystem.
- Formed a strategic collaboration with Sarla Aviation to support the development of 'Shunya', India's first indigenous electric vertical takeoff and landing (eVTOL) aircraft.
- Won an engagement from a global aerospace supplier for development of a test rig and validation of commercial aircraft systems.
- Secured an AI engagement with a global technology leader to build a GenAI multilingual virtual assistant.
- Won a strategic engagement from a global renal care leader for end-to-end product engineering of next-gen home dialysis systems.
- US and India geographies demonstrated strong growth, whereas Europe auto demand remained soft with delayed OEM decision-making.
Analyst Q&A
Q. Can management provide any revision to full-year FY27 guidance given the 15% H1 growth?
As a company policy, Tata Elxsi does not provide quantitative guidance, so there is no formal guidance revision.
Q. What is the revenue concentration and drag from European auto and key group clients like JLR and Tata Motors?
Management declined to break out exact revenue share for Europe vs North America/APAC or individual group client concentration, but noted most auto growth is coming from outside group customers and non-Europe regions.
Q. What are the margin differences between fixed-price and T&M contracts and internal target splits?
Management explained that margins are driven by skill premium and strategic client value rather than contracting model, maintaining an industry-leading onsite-offshore revenue mix of ~25:75.
Research and educational content only. Not investment advice.